Intriguingly, we noticed relatively higher expression levels of anti-inflammatory (IL1R2) [41] and immune suppressive (RETN) genes in MDSC monocytes of hospitalized COVID-19 patients with the use of ACEis; consistent with the immunosuppression function of MDSCs. The gene discussed is IL1R2; the disease is COVID-19.